Search Results - "Princet, Isabelle"
-
1
Cost and efficacy of peripheral stem cell mobilization strategies in multiple myeloma
Published in Bone marrow transplantation (Basingstoke) (01-12-2020)“…Mobilization of peripheral blood stem cells (PBSC) can be performed using plerixafor, which is expensive, or high-dose cyclophosphamide (HDCy). We hypothesized…”
Get full text
Journal Article -
2
Lenalidomide and Rituximab Combined with CEP Chemotherapy (R2CEP) for Patients with Relapsed or Refractory B-Cell Lymphoma
Published in Blood (29-11-2018)“…Background. Patients with relapse or refractory (R/R) B-cell Non Hodgkin Lymphoma (B-NHL), especially DLBCL, have a poor prognostic in relation to the…”
Get full text
Journal Article -
3
Oral CHOP-like Chemotherapy in Elderly Patients with High-Grade Non Hodgkin B Cell Lymphoma
Published in Blood (29-11-2018)“…Background. The Doxorubicin based R-CHOP regimen remains the standard of care for the upfront treatment of DLBCL. The advent of oral idarubicin permitted to…”
Get full text
Journal Article -
4
Waldenström macroglobulinemia and relationship to immune deficiency
Published in Leukemia & lymphoma (19-09-2021)“…Primary or secondary immune deficiency (ID) is a risk factor, although rare, to develop Waldenström macroglobulinemia (WM). We aimed to better understand the…”
Get full text
Journal Article -
5
Carfilzomib weekly 20/56mg/m², lenalidomide and dexamethasone for early relapsed refractory multiple myeloma
Published in Journal of clinical oncology (20-05-2018)“…Abstract only…”
Get full text
Journal Article -
6
Oral CHOP‐like chemotherapy in 60–80 years‐old patients with diffuse large B‐cell lymphoma
Published in British journal of haematology (01-09-2019)Get full text
Journal Article -
7
Carfilzomib Weekly 20/56mg/m², Lenalidomide and Dexamethasone for Early Relapsed Refractory Multiple Myeloma
Published in Blood (29-11-2018)“…Background. Triplet-based lenalidomide plus dexamethasone combinations have become the new standard of care for early RRMM, including with carfilzomib (KRd)…”
Get full text
Journal Article -
8
Chronic HCV Infection and Autologous Stem Cell Transplantation for Multiple Myeloma
Published in Blood (29-11-2018)“…Introduction. The pronostic of Chronic hepatitis C (Hep C) has transformed towards cure in recent years with the advent of the antiviral treatment by…”
Get full text
Journal Article -
9
Pomalidomide 3rd Line Versus 4th Line for RRMM
Published in Blood (08-12-2017)“…Background. Pomalidomide in association with dexamethasone is approved for RRMM in 3rd line and beyond based on the multicenter international phase 3MM-003…”
Get full text
Journal Article -
10
Carfilzomib Weekly 20/56mg/m², Lenalidomide and Dexamethasone for Early Relapsed Refractory Multiple Myeloma
Published in Blood (08-12-2017)“…Background. Triplet-based lenalidomide plus dexamethasone combinations have become the new standard of care for early relapse and refractory multiple myeloma…”
Get full text
Journal Article -
11
Carfilzomib weekly 20/56 mg/m2, lenalidomide and dexamethasone for early relapsed refractory multiple myeloma
Published in American journal of hematology (01-01-2019)Get full text
Journal Article -
12
Carfilzomib weekly 20/56 mg/m 2 , lenalidomide and dexamethasone for early relapsed refractory multiple myeloma
Published in American journal of hematology (01-01-2019)Get full text
Journal Article -
13
Use of complementary medicines by patients treated with chemotherapy: Survey in a French day care unit
Published in Journal of clinical oncology (20-05-2012)“…Abstract only e19555 Background: Nowadays, communication about alternative medicines and biologic therapies is very intense. Anyone can find information, more…”
Get full text
Journal Article